Newly Activated #NCTN #HeadAndNeckCancer #ThyroidCancer Trial: (EA3231) A Randomized Phase III Study of BRAF-Targeted Therapy vs Cabozantinib in RAI-Refractory Differentiated Thyroid Cancer with BRAF V600Em, led by ECOG-ACRIN Cancer Research Group Learn more: buff.ly/4eiwKyf

.Amer Zeidan MBBS,MHS ‏عامر زيدان of Smilow Cancer Hospital & Yale Cancer Center is leading clinical study EA9171, testing if adding a new drug to the usual treatment for chronic myelogenous #leukemia could help patients. Learn more: bit.ly/ea9171-study #CML #leusm

#ClinicalTrial EAQ221CD/CONCURxP monitors CDK4/6 inhibitor medication use with text message reminders & alerts for patients treated for #BreastCancer. For more information: bit.ly/EAQ221CD #bcsm cc: Gelareh Sadigh, MD, Ilana G

In honor of #BloodCancerAwarenessMonth 🩸, learn about #ClinicalTrial EA9171! This trial is studying a potential new treatment for patients with chronic myelogenous #leukemia (#CML). More info: bit.ly/ea9171-study #leusm #BCAM cc: Amer Zeidan MBBS,MHS ‏عامر زيدان

ComboMATCH/EAY191-E5 tests how well #sotorasib with or without #panitumumab can treat patients with advanced #SolidTumors. For more information: bit.ly/combomatch-e5 cc: NCI Treatment, Kristen Spencer, Dustin Deming #PrecisionMedicine

Do you have advanced non-small cell #LungCancer and are aged 70 or older? If so, you may be able to participate in this study of a new treatment approach. Learn more: bit.ly/ea5221-achieve cc: Balazs Halmos Efrat Dotan MD Carolyn Presley, MD MHS

Do you have #HER2positive #BreastCancer? If so, you may be eligible to participate in the phase 2 #ClinicalTrial EA1211/DIRECT, testing if FDG-PET/CT imaging can better predict a patient's response to treatment than the usual approach. Learn more: bit.ly/EA1211

Do you have advanced #cancer that has become worse following treatment, or advanced cancer for which no standard treatment exists? If so, you may be able to join the #ComboMATCH #PrecisionMedicine study. Learn more: bit.ly/ComboMATCH

Clinical study EA3191 is testing a new treatment approach for patients with squamous cell carcinoma of the head and neck (#HNSCC) that has come back after initial therapy. Learn more: bit.ly/ea3191-study #HeadAndNeckCancer #HNCA

EA2197 is a randomized phase 2/3 #ClinicalTrial assessing the optimal perioperative approach for patients with incidental #GallbladderCancer. Learn more: bit.ly/EA2197 cc: Shishir K. Maithel Winship Cancer Institute of Emory University

There is still time to submit a research abstract for early-career investigators interested in presenting your research as part of the upcoming Fall 2024 Group Meeting. The submission deadline is tomorrow, Thursday, September 12 at 11:59 PM (Eastern Time). ecog-acrin.org/research/mento…

Learn about the EA8191/INDICATE study, treating #ProstateCancer that has come back after surgery with apalutamide and targeted radiation based on PET imaging. More information: bit.ly/indicate-trial #pcsm

Do you have #Cancer (any form of #SolidTumor) that has been recently diagnosed, & a new prescription for cancer medication? If so, you may be able to participate in a research study that aims to reduce #FinancialHardship. More info here: bit.ly/EAQ222CD cc: Gelareh Sadigh, MD

Chemotherapy before surgery helps patients with nose and sinus #cancer avoid debilitating eye and bone removal. Striking #clinicaltrial results at #ESMO24. #CancerSurgery Nabil Saba, MD Winship Cancer Institute of Emory University Barbara Burtness Yale Cancer Center @NCI_CTEP tinyurl.com/EA3163-ESMO24

Do you have squamous cell carcinoma of the head and neck that has spread to a limited number of places? If so, you may be eligible to participate in this study of a potential new treatment. Learn more: bit.ly/ea3211-study #HeadAndNeckCancer #HNSCC

Are you a teen or young adult #lymphoma survivor that has finished treatment? If so, you may be eligible to participate in the The AYA Social Genomics Study study that could make a positive impact on the #AYA #cancer community. Learn more: bit.ly/eaq211-study #AYACancer #AYACSM

Could #greentea catechins help prevent the progression of #prostatecancer in men on active surveillance? #Clinicaltrial EA8184, led by Dr. Nagi Kumar of Moffitt Cancer Center, aims to find out. Learn more: bit.ly/ea8184-trial #pcsm cc: juan luis pow sang campos

Do you have #esophageal or #GastricCancer that has spread to a number of places in your body? If the #cancer has spread to 1–3 places, you may be able to participate in #clinicaltrial EA2183. For more info: bit.ly/ea2183

Do you have #KidneyCancer (#RenalCellCarcinoma) that has spread to 2-5 other locations in your body? If so, you may be able to participate in this study of a potential new treatment. Learn more: bit.ly/ea8211-study #kcsm

In #ClinicalTrial EA2222/PUMP, investigators are testing #PumpChemo in addition to SOC chemo versus SOC chemo alone for patients with unresectable #ColorectalCancer liver metastases. For more: bit.ly/ea2222-pump cc : Michael Lidsky, MD, FACS